세계의 섬유근육통 디지털 치료제 시장 보고서(2025년)

Digital therapeutics for fibromyalgia are health applications and online programs that provide structured therapy and monitor symptoms to support daily self-management. They aim to reduce pain and fatigue, enhance sleep and functionality, and offer patients and clinicians valuable data for personalized care.

The primary product types of digital therapeutics for fibromyalgia include software applications, devices, and platforms. Software applications are clinically validated programs designed to deliver therapeutic interventions for managing fibromyalgia symptoms such as pain and fatigue. These solutions are available through both online and offline channels. Key applications include chronic pain management, sleep disorder management, fatigue management, and others, with main end users being hospitals, clinics, homecare providers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The digital therapeutics for fibromyalgia market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics for fibromyalgia market statistics, including the digital therapeutics for fibromyalgia industry global market size, regional shares, competitors with the digital therapeutics for fibromyalgia market share, detailed digital therapeutics for fibromyalgia market segments, market trends, and opportunities, and any further data you may need to thrive in the digital therapeutics for fibromyalgia industry. This digital therapeutics for fibromyalgia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The digital therapeutics for fibromyalgia market size has grown exponentially in recent years. It will grow from $0.98 billion in 2024 to $1.19 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth during the historic period is attributed to increasing clinical recognition of fibromyalgia and earlier diagnosis, a shift toward home-based self-management during the coronavirus pandemic, insurer and employer preference for nonpharmacological pain management, opioid stewardship policies supporting behavioral pain therapies, and rising patient preference for low-risk, non-drug pain interventions.

The digital therapeutics for fibromyalgia market size is expected to see exponential growth in the next few years. It will grow to $2.54 billion in 2029 at a compound annual growth rate (CAGR) of 20.9%. The growth during the forecast period is attributed to the expansion of reimbursement for evidence-based digital interventions, increasing integration into rheumatology and primary care pathways, rising prevalence and symptom burden in aging populations, greater emphasis on women's health and chronic pain equity, and cost-containment pressures to reduce unnecessary imaging and visits. Key trends in the forecast period include prescription digital therapeutics providing acceptance and commitment therapy programs, virtual reality-based pain distraction and rehabilitation modules, augmented reality-guided movement therapy and posture training, artificial intelligence-driven personalization of therapy content and pacing, and natural language processing-powered coaching and symptom triage.

The increasing awareness of digital health solutions is expected to drive the growth of the digital therapeutics for fibromyalgia market in the coming years. Digital health solutions include software-enabled tools and services such as patient apps, patient portals, and virtual-care platforms that provide information, monitoring, and therapy through digital channels. This growing awareness is fueled by government-supported initiatives and widespread adoption of official health apps that normalize online access to care. Digital therapeutics for fibromyalgia leverage these familiar channels to streamline onboarding and adherence to app-based cognitive behavioral therapy, pacing, and sleep programs while allowing clinician oversight. For example, in December 2023, the UK National Health Service reported that digital health app users reached 33.6 million, up from 16.8 million in 2022, with monthly logins increasing 54% from 16.8 million to 25.8 million. This demonstrates how increasing awareness of digital health solutions is propelling the digital therapeutics for fibromyalgia market.

Key companies in the digital therapeutics for fibromyalgia market are focusing on technological advancements, such as computerized behavioral therapy devices, to deliver evidence-based interventions that improve pain management, reduce fatigue, enhance sleep quality, and support mental health through scalable, patient-centric digital platforms. A computerized behavioral therapy device is a software-based platform or application that provides structured, evidence-based cognitive or behavioral therapy interventions remotely, using interactive modules, exercises, and real-time feedback to manage fibromyalgia symptoms. For instance, in May 2023, US-based Swing Therapeutics, Inc. launched Stanza following U.S. FDA De Novo marketing authorization (DEN220083). The program offers a 12-week, self-guided acceptance and commitment therapy (ACT) program for fibromyalgia, with a randomized controlled trial in The Lancet reporting significant clinical improvements. It is delivered via smartphone (iOS or Android), allowing patients to access therapy conveniently at home.

In February 2025, US-based XRHealth Inc., a therapeutic extended reality (XR) and digital therapeutics company, acquired RealizedCare for an undisclosed amount. Through this acquisition, XRHealth aims to integrate RealizedCare's immersive digital therapeutics content and artificial intelligence triage tool into its platform to expand evidence-based care for chronic pain and behavioral health, including its existing fibromyalgia programs, while scaling AI-enabled, value-based delivery and enhancing clinician oversight and personalization. RealizedCare is a US-based immersive digital therapeutics company specializing in chronic pain and behavioral health.

Major players in the digital therapeutics for fibromyalgia market are Grunenthal GmbH, Hinge Health Inc., DarioHealth Corp., Kaia Health, CogniFit Inc., Big Health Ltd., Remedee Labs, HelloBetter GmbH, AppliedVR Inc., PainDrainer, Swing Therapeutics Inc., Fern Health Inc., JOGO Health Inc., LIN Health Inc., MoreGoodDays, Happify Health Inc., Click Therapeutics Inc., Wellthy Therapeutics Pvt. Ltd., FlexifyMe, SleepioRx.

North America was the largest region in the digital therapeutics for fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Digital Therapeutics For Fibromyalgia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics for fibromyalgia market consists of revenues earned by entities by providing services such as remote health coaching and therapist support, tele-physiotherapy consultations, adherence and engagement services, and outcomes analytics and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics for fibromyalgia market also includes sales of cognitive behavioral therapy (cbt) apps, pain neuroscience education modules, digital graded exercise and activity pacing programs, virtual reality-based pain distraction experiences, and sleep hygiene and relaxation programs, clinician dashboards and care coordination tools, patient. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics For Fibromyalgia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics for fibromyalgia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics for fibromyalgia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics for fibromyalgia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Software Applications; Devices; Platforms
• 2) By Therapy Area: Cognitive Behavioral Therapy; Mindfulness-Based Interventions; Pain Management; Other Therapy Types
• 3) By Distribution Channel: Online; Offline
• 4) By Application: Chronic Pain Management; Sleep Disorders; Fatigue Management; Other Applications
• 5) By End-User: Hospitals; Clinics; Homecare; Other End-Users
• Subsegment:
• 1) By Software Applications: Mobile Applications; Web-Based Applications; Cloud-Based Applications; Virtual Reality Applications
• 2) By Devices: Wearable Devices; Handheld Devices; Smart Monitoring Devices; Connected Therapeutics Devices
• 3) By Platforms: Telehealth Platforms; Remote Monitoring Platforms; Patient Engagement Platforms; Data Analytics Platforms
• Companies Mentioned: Grunenthal GmbH; Hinge Health Inc.; DarioHealth Corp.; Kaia Health; CogniFit Inc.; Big Health Ltd.; Remedee Labs; HelloBetter GmbH; AppliedVR Inc.; PainDrainer; Swing Therapeutics Inc.; Fern Health Inc.; JOGO Health Inc.; LIN Health Inc.; MoreGoodDays; Happify Health Inc.; Click Therapeutics Inc.; Wellthy Therapeutics Pvt. Ltd.; FlexifyMe; SleepioRx
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Therapeutics For Fibromyalgia Market Characteristics

3. Digital Therapeutics For Fibromyalgia Market Trends And Strategies

4. Digital Therapeutics For Fibromyalgia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics For Fibromyalgia Growth Analysis And Strategic Analysis Framework

• 5.1. Global Digital Therapeutics For Fibromyalgia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Digital Therapeutics For Fibromyalgia Market Growth Rate Analysis
• 5.4. Global Digital Therapeutics For Fibromyalgia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Digital Therapeutics For Fibromyalgia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Digital Therapeutics For Fibromyalgia Total Addressable Market (TAM)

6. Digital Therapeutics For Fibromyalgia Market Segmentation

• 6.1. Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software Applications
• Devices
• Platforms
• 6.2. Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive Behavioral Therapy
• Mindfulness-Based Interventions
• Pain Management
• Other Therapy Types
• 6.3. Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online
• Offline
• 6.4. Global Digital Therapeutics For Fibromyalgia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Pain Management
• Sleep Disorders
• Fatigue Management
• Other Applications
• 6.5. Global Digital Therapeutics For Fibromyalgia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare
• Other End-Users
• 6.6. Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Software Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mobile Applications
• Web-Based Applications
• Cloud-Based Applications
• Virtual Reality Applications
• 6.7. Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wearable Devices
• Handheld Devices
• Smart Monitoring Devices
• Connected Therapeutics Devices
• 6.8. Global Digital Therapeutics For Fibromyalgia Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Telehealth Platforms
• Remote Monitoring Platforms
• Patient Engagement Platforms
• Data Analytics Platforms

7. Digital Therapeutics For Fibromyalgia Market Regional And Country Analysis

• 7.1. Global Digital Therapeutics For Fibromyalgia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Digital Therapeutics For Fibromyalgia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics For Fibromyalgia Market

• 8.1. Asia-Pacific Digital Therapeutics For Fibromyalgia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics For Fibromyalgia Market

• 9.1. China Digital Therapeutics For Fibromyalgia Market Overview
• 9.2. China Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics For Fibromyalgia Market

• 10.1. India Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics For Fibromyalgia Market

• 11.1. Japan Digital Therapeutics For Fibromyalgia Market Overview
• 11.2. Japan Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics For Fibromyalgia Market

• 12.1. Australia Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics For Fibromyalgia Market

• 13.1. Indonesia Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics For Fibromyalgia Market

• 14.1. South Korea Digital Therapeutics For Fibromyalgia Market Overview
• 14.2. South Korea Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics For Fibromyalgia Market

• 15.1. Western Europe Digital Therapeutics For Fibromyalgia Market Overview
• 15.2. Western Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics For Fibromyalgia Market

• 16.1. UK Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics For Fibromyalgia Market

• 17.1. Germany Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics For Fibromyalgia Market

• 18.1. France Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics For Fibromyalgia Market

• 19.1. Italy Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics For Fibromyalgia Market

• 20.1. Spain Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics For Fibromyalgia Market

• 21.1. Eastern Europe Digital Therapeutics For Fibromyalgia Market Overview
• 21.2. Eastern Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics For Fibromyalgia Market

• 22.1. Russia Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics For Fibromyalgia Market

• 23.1. North America Digital Therapeutics For Fibromyalgia Market Overview
• 23.2. North America Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics For Fibromyalgia Market

• 24.1. USA Digital Therapeutics For Fibromyalgia Market Overview
• 24.2. USA Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics For Fibromyalgia Market

• 25.1. Canada Digital Therapeutics For Fibromyalgia Market Overview
• 25.2. Canada Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics For Fibromyalgia Market

• 26.1. South America Digital Therapeutics For Fibromyalgia Market Overview
• 26.2. South America Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics For Fibromyalgia Market

• 27.1. Brazil Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics For Fibromyalgia Market

• 28.1. Middle East Digital Therapeutics For Fibromyalgia Market Overview
• 28.2. Middle East Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics For Fibromyalgia Market

• 29.1. Africa Digital Therapeutics For Fibromyalgia Market Overview
• 29.2. Africa Digital Therapeutics For Fibromyalgia Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Digital Therapeutics For Fibromyalgia Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Digital Therapeutics For Fibromyalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics For Fibromyalgia Market Competitive Landscape And Company Profiles

• 30.1. Digital Therapeutics For Fibromyalgia Market Competitive Landscape
• 30.2. Digital Therapeutics For Fibromyalgia Market Company Profiles
  • 30.2.1. Grunenthal GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Hinge Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. DarioHealth Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Kaia Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CogniFit Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics For Fibromyalgia Market Other Major And Innovative Companies

• 31.1. Big Health Ltd.
• 31.2. Remedee Labs
• 31.3. HelloBetter GmbH
• 31.4. AppliedVR Inc.
• 31.5. PainDrainer
• 31.6. Swing Therapeutics Inc.
• 31.7. Fern Health Inc.
• 31.8. JOGO Health Inc.
• 31.9. LIN Health Inc.
• 31.10. MoreGoodDays
• 31.11. Happify Health Inc.
• 31.12. Click Therapeutics Inc.
• 31.13. Wellthy Therapeutics Pvt. Ltd.
• 31.14. FlexifyMe
• 31.15. SleepioRx

32. Global Digital Therapeutics For Fibromyalgia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics For Fibromyalgia Market

34. Recent Developments In The Digital Therapeutics For Fibromyalgia Market

35. Digital Therapeutics For Fibromyalgia Market High Potential Countries, Segments and Strategies

• 35.1 Digital Therapeutics For Fibromyalgia Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Digital Therapeutics For Fibromyalgia Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Digital Therapeutics For Fibromyalgia Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer